Analyst Ratings for Rigel Pharmaceuticals (RIGL) [Buys]

RIGL Rating Summary

RIGL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RIGL
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $6.00 (+130.8%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/6/2012 Leerink Swann
» Updated 8/26/2013
New Coverage Outperform
(N/A)
5.00
(7.00)
9.89 2.60 -73.71% Details
9/29/2011 JPMorgan New Coverage Overweight
(N/A)
14.00
(N/A)
6.97 2.60 -62.7% Details